Patents by Inventor Michael GORMALLY

Michael GORMALLY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • T CELL RECEPTORS TARGETING TP53 HOTSPOT MUTATIONS AND USES THEREOF
    Publication number: 20260232801
    Abstract: Provided and featured are novel recombinant T cell receptors (TCRs) that target a mutated tumor suppressor TP53. Also provided are cells comprising such TCRs, and methods of using the recombinant TCRs and cells expressing the recombinant TCRs for treating cancers associated with mutated TP53.
    Type: Application
    Filed: January 22, 2026
    Publication date: August 13, 2026
    Applicants: MEMORIAL SLOAN-KETTERING CANCER CENTER, SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH, MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES
    Inventors: Michael GORMALLY, Smita S. CHANDRAN, Christopher A. KLEBANOFF